ITGA2B and cancer: ITGA2B (integrin alpha-IIb;CD41) and ITGB3 (integrin alpha-V beta 3;CD61) can be expressed by CTCs and are critical for the platelet-cancer cell interaction, as inhibition of ITGB3 prevents the platelet-tumour cell interactions [67].